Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Peter Horby, Marion Mafham, Louise Linsell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Marion Mafham, Jennifer Bell, et al.
The Lancet (2020) Vol. 396, Iss. 10259, pp. 1345-1352
Open Access | Times Cited: 701
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Caleb P Skipper, Katelyn A Pastick, Nicole Engen, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 8, pp. 623-631
Open Access | Times Cited: 533
Immunopathology of Hyperinflammation in COVID-19
Joshua Gustine, Dennis Jones
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 4-17
Open Access | Times Cited: 480
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages
Els Wauters, Pierre Van Mol, Abhishek D. Garg, et al.
Cell Research (2021) Vol. 31, Iss. 3, pp. 272-290
Open Access | Times Cited: 321
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 19-27
Open Access | Times Cited: 295
COVID-19: A review of therapeutic strategies and vaccine candidates
Vladislav Izda, Matlock A. Jeffries, Amr H. Sawalha
Clinical Immunology (2020) Vol. 222, pp. 108634-108634
Open Access | Times Cited: 272
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 629-646
Open Access | Times Cited: 257
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
Nadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 8
Open Access | Times Cited: 218
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim, Min Ho An, Won Jun Kim, et al.
PLoS Medicine (2020) Vol. 17, Iss. 12, pp. e1003501-e1003501
Open Access | Times Cited: 203
Systemic corticosteroids for the treatment of COVID-19
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 199
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 166
Drug repurposing for COVID-19 via knowledge graph completion
Rui Zhang, Dimitar Hristovski, Dalton Schutte, et al.
Journal of Biomedical Informatics (2021) Vol. 115, pp. 103696-103696
Open Access | Times Cited: 160
The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review
Philip James, Zakari Ali, Andrew E. Armitage, et al.
Journal of Nutrition (2021) Vol. 151, Iss. 7, pp. 1854-1878
Open Access | Times Cited: 128
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 120
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
Parastoo Tarighi, S. Eftekhari, Milad Chizari, et al.
European Journal of Pharmacology (2021) Vol. 895, pp. 173890-173890
Open Access | Times Cited: 116
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
Sherief Abd‐Elsalam, Eslam Saber Esmail, Mai Khalaf, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 103, Iss. 4, pp. 1635-1639
Open Access | Times Cited: 135
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Zakariya Kashour, Muhammad Riaz, Musa A. Garbati, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 1, pp. 30-42
Open Access | Times Cited: 125
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
Lucy Catteau, Nicolás Dauby, Marion Montourcy, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 4, pp. 106144-106144
Open Access | Times Cited: 121
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
Chunxue Bai, Sanjay H. Chotirmall, Jordi Rello, et al.
European Respiratory Review (2020) Vol. 29, Iss. 157, pp. 200287-200287
Open Access | Times Cited: 120
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal
Mohammad Sultan Khuroo
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 3, pp. 106101-106101
Open Access | Times Cited: 117
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
European Journal of Internal Medicine (2020) Vol. 82, pp. 38-47
Open Access | Times Cited: 110
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
Pankaj Bansal, Amandeep Goyal, Austin Cusick, et al.
Annals of Medicine (2020) Vol. 53, Iss. 1, pp. 117-134
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top